The ability to efficiently isolate antigen-specific monoclonal antibodies (mAbs) has caused explosive growth in our understanding of antibody-mediated immunity, and has enabled the rapid generation of novel therapeutics and diagnostics. However, the traditional monoclonal antibody discovery procedures are labor- and time-intensive and low efficiency.

CD's excellent R&D team has mastered a variety of emerging technologies and can provide customized antibody services for clients based on single B cell cloning technology. https://www.creative-diagn...